Valuation: CellaVision AB

Capitalization 3.78B 423M 356M 325M 310M 575M 38.4B 597M 1.5B 18.45B 1.59B 1.55B 66.06B P/E ratio 2025 *
24.6x
P/E ratio 2026 * 21.6x
Enterprise value 3.62B 406M 341M 311M 297M 551M 36.79B 572M 1.43B 17.68B 1.52B 1.49B 63.28B EV / Sales 2025 *
4.79x
EV / Sales 2026 * 4.31x
Free-Float
82.65%
Yield 2025 *
1.66%
Yield 2026 * 1.77%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.77%
1 week+13.76%
Current month+8.82%
1 month+1.52%
3 months+0.25%
6 months-2.91%
Current year+2.04%
More quotes
1 week 139.2
Extreme 139.2
165
1 month 139.2
Extreme 139.2
165
Current year 139.2
Extreme 139.2
165
1 year 139.2
Extreme 139.2
208
3 years 120
Extreme 120
302
5 years 120
Extreme 120
503.5
10 years 44.7
Extreme 44.7
503.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 55 2021-03-20
Director of Finance/CFO 46 2025-09-01
Sales & Marketing 62 2021-12-31
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.77%+13.76%-20.40%-22.70% 423M
+0.67%-7.39%-6.28%-46.61% 17.14B
+0.73%-0.80%+97.90%+142.33% 2.52B
+0.55%+5.82%-31.78%-65.89% 1.99B
+0.63%+1.00%-24.32%-17.62% 1.12B
+0.71%+2.55%+13.80%-40.64% 909M
+0.85%-2.40%+5.06%-43.85% 832M
-1.37%+0.10%-35.05%-47.49% 626M
+0.29%-0.85%+14.43%-25.56% 589M
Average +0.54%+1.63%+1.48%-18.67% 2.91B
Weighted average by Cap. +0.63%+1.49%+1.65%-27.49%
See all sector performances

Financials

2025 *2026 *
Net sales 757M 84.66M 71.13M 65.01M 61.93M 115M 7.68B 119M 299M 3.69B 318M 311M 13.21B 825M 92.29M 77.54M 70.87M 67.51M 125M 8.37B 130M 326M 4.02B 346M 339M 14.4B
Net income 154M 17.2M 14.45M 13.21M 12.58M 23.35M 1.56B 24.27M 60.83M 750M 64.5M 63.18M 2.68B 175M 19.57M 16.44M 15.03M 14.32M 26.56M 1.78B 27.61M 69.21M 853M 73.39M 71.88M 3.05B
Net Debt -159M -17.76M -14.92M -13.64M -12.99M -24.1M -1.61B -25.06M -62.8M -774M -66.59M -65.23M -2.77B -232M -25.97M -21.82M -19.94M -19M -35.25M -2.36B -36.65M -91.85M -1.13B -97.4M -95.4M -4.05B
More financial data * Estimated data
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
231
More about the company
Date Price Change Volume
26-02-10 160.40 kr +1.13% 10,111
26-02-09 158.60 kr -2.70% 25,507
26-02-06 163.00 kr +3.82% 98,637
26-02-05 157.00 kr +11.35% 235,031
26-02-04 141.00 kr 0.00% 15,891

Delayed Quote Nasdaq Stockholm, February 10, 2026 at 06:41 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
158.60SEK
Average target price
228.75SEK
Spread / Average Target
+44.23%
Consensus

Quarterly revenue - Rate of surprise